NL6514403A - - Google Patents

Info

Publication number
NL6514403A
NL6514403A NL6514403A NL6514403A NL6514403A NL 6514403 A NL6514403 A NL 6514403A NL 6514403 A NL6514403 A NL 6514403A NL 6514403 A NL6514403 A NL 6514403A NL 6514403 A NL6514403 A NL 6514403A
Authority
NL
Netherlands
Application number
NL6514403A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DEC24871A external-priority patent/DE1186078B/de
Priority claimed from DEC25468A external-priority patent/DE1210883B/de
Application filed filed Critical
Publication of NL6514403A publication Critical patent/NL6514403A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL6514403A 1961-08-12 1965-11-05 NL6514403A (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DEC24871A DE1186078B (de) 1961-08-12 1961-08-12 Verfahren zur Herstellung von Derivaten des 7-Oxy-cumarins
DEC25468A DE1210883B (de) 1961-11-09 1961-11-09 Verfahren zur Herstellung von Derivaten des 7-Oxycumarins
DEC0026091 1962-01-26
DEC0026092 1962-01-26

Publications (1)

Publication Number Publication Date
NL6514403A true NL6514403A (de) 1966-01-25

Family

ID=27436691

Family Applications (2)

Application Number Title Priority Date Filing Date
NL281975D NL281975A (de) 1961-08-12
NL6514403A NL6514403A (de) 1961-08-12 1965-11-05

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL281975D NL281975A (de) 1961-08-12

Country Status (8)

Country Link
US (1) US3282938A (de)
AT (1) AT238716B (de)
CH (1) CH415676A (de)
DK (1) DK105069C (de)
FR (1) FR1332328A (de)
GB (1) GB1014053A (de)
NL (2) NL6514403A (de)
SE (1) SE303508B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1259349B (de) * 1964-10-17 1968-01-25 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Derivaten des 7-Oxycumarins
US3515721A (en) * 1967-06-26 1970-06-02 Cassella Farbwerke Mainkur Ag 3-tertiary-aminoethyl-4-methyl or phenyl-7-ethoxycarbonylmethoxy - halo or mononitro coumarins and congeners
US3625976A (en) * 1969-12-09 1971-12-07 Int Flavors & Fragrances Inc Coumarin ether sun-screening compounds
US3859311A (en) * 1972-02-25 1975-01-07 Universal Oil Prod Co Preparation of coumarins
IT1160365B (it) * 1978-12-19 1987-03-11 F I D I A Spa Applicazioni in campo farmacologico e terapeutico dell'8-cloro-3-(beta-dietilamincetil)-4-metil-7-etossi-carbonilmetossicumarina cloridrato preparato allo stato puro mediante procedimento selettivo, con particolare riguardo alla sua azione antiaritmica
US5247099A (en) * 1989-08-17 1993-09-21 Abbott Laboratories Process for synthesis of 7-hydroxy coumarins having substitutions in the 4-position
IT1247476B (it) * 1991-06-14 1994-12-17 Fidia Spa Derivati della cumarina.
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
KR100638399B1 (ko) 2005-06-09 2006-10-25 한국화학연구원 4-히드록시쿠마린 유사체의 제조방법
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
EP2321341B1 (de) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Zur behandlung von erkrankungen des magen-darm-trakts, entzündlichen erkrankungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP6000456B2 (ja) 2012-07-27 2016-09-28 サン ケミカル コーポレイション インクにおける光開始剤および光増感剤としてのケトクマリン
EP2970384A1 (de) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonisten der guanylatcyclase und deren verwendungen
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US10703735B2 (en) * 2018-07-25 2020-07-07 Lead Discovery Center Gmbh 4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2498497A (en) * 1949-06-10 1950-02-21 Sterling Drug Inc 2[2(phthalimido)ethyl]pyridines
BE535749A (de) * 1954-02-08
US2980673A (en) * 1954-10-14 1961-04-18 Cutter Lab Bis-quaternary ammonium esters of amino-carboxylic acids and aminoalcohols
US2844591A (en) * 1955-10-14 1958-07-22 Mead Johnson & Co 1-substituted-3-pyrrolidylmethyl benzilates and salts thereof
US3074953A (en) * 1962-01-17 1963-01-22 American Home Prod 5-(3'-(4-phenyl-4-carbethoxy piperidino)-propylidene) dibenzo (a,d) (1,4) cycloheptadiene

Also Published As

Publication number Publication date
DK105069C (da) 1966-08-15
CH415676A (de) 1966-06-30
FR1332328A (fr) 1963-07-12
NL281975A (de)
SE303508B (de) 1968-09-02
AT238716B (de) 1965-02-25
GB1014053A (en) 1965-12-22
US3282938A (en) 1966-11-01

Similar Documents

Publication Publication Date Title
BE614497A (de)
BE482264A (de)
BE396226A (de)
BE458606A (de)
BE464928A (de)
BE469342A (de)
BE472265A (de)
BE475425A (de)
BE475477A (de)
BE476407A (de)
BE478349A (de)
BE615256A (de)
BE493336A (de)
BE567723A (de)
BE568568A (de)
BE583834A (de)
BE587184A (de)
BE596839A (de)
BE597352A (de)
BE597570A (de)
BE598861A (de)
BE599016A (de)
BE599210A (de)
BE599528A (de)
BE599922A (de)